Evidence map›Paper›PMID 29603575›Full record

ArticleBJU international2018

Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.

Ray C J Hsu, Matthew Barclay, Molly A Loughran, Georgios Lyratzopoulos, Vincent J Gnanapragasam, James N Armitage

Open access · hybridAbstract read
In one paragraph

Article in BJU international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ray C J HsuAcademic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0959-1666
Matthew BarclayThe Healthcare Improvement Studies (THIS) Institute, University of Cambridge, Cambridge, UK.
Molly A LoughranTransforming Cancer Services Team, National Health Service, London, UK.
Georgios LyratzopoulosThe Healthcare Improvement Studies (THIS) Institute, University of Cambridge, Cambridge, UK.
Vincent J GnanapragasamAcademic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.
James N ArmitageDepartment of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
University of Cambridge · GBCambridge University Hospitals NHS Foundation Trust · GBNational Health Service · GB

Funding

Cancer Research UK 18180Cancer Research UK C18081/A18180
6 · The paper itself

Abstract

objectiveTo describe the temporal trends in nephrectomy practice and outcomes for English patients with renal cell carcinoma (RCC). PATIENTS AND

methodsAdult RCC nephrectomy patients treated between 2000 and 2010 were identified in the National Cancer Data Repository and Hospital Episode Statistics, and followed-up until date of death or 31 December 2015 (n = 30 763). We estimated the annual frequency for each nephrectomy type, the hospital and surgeon numbers and their case volumes. We analysed short-term surgical outcomes, as well as 1- and 5-year relative survivals.

resultsAnnual RCC nephrectomy number increased by 66% during the study period. Hospital number decreased by 24%, whilst the median annual hospital volume increased from 10 to 23 (P < 0.01). Surgeon number increased by 27% (P < 0.01), doubling the median consultant number per hospital. The proportion of minimally invasive surgery (MIS) nephrectomies rose from 1% to 46%, whilst the proportion of nephron-sparing surgeries (NSS) increased from 5% to 16%, with 29% of all T1 disease treated with partial nephrectomy in 2010 (P < 0.01). The 30-day mortality rate halved from 2.4% to 1.1% and 90-day mortality decreased from 4.9% to 2.6% (P < 0.01). The 1-year relative survival rate increased from 86.9% to 93.4%, whilst the 5-year relative survival rate rose from 68.2% to 81.2% (P < 0.01). Improvements were most notable in patients aged ≥65 years and those with T3 and T4 disease.

conclusionsSurgical RCC management has changed considerably with nephrectomy centralisation and increased NSS and MIS. In parallel, we observed significant improvements in short- and long-term survival particularly for elderly patients and those with locally advanced disease.

Indexed as

AgedDelivery of Health CareEnglandFemaleHumansKidney NeoplasmsMaleMiddle AgedNephrectomyNephronsOrgan Sparing TreatmentsPractice Patterns, Physicians'Retrospective StudiesSurvival AnalysisTime FactorsTreatment Outcomecentralisation#KidneyCancernephrectomypostoperative outcomesrenal cancersurvival

Identifiers

PMID29603575
PMCPMC6175431
OpenAlexW2794658825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.